Original Source(s)
Related Content
FDA Clears Self-Administered Lupus Therapy
Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.
April 28, 2026
-
2 min
Hair Repigmentation Reported With Baricitinib in Canities Subita
A single case suggests a possible benefit, but confounding factors and the off-label setting temper the conclusions.
June 15, 2026
-
4 min
Achieving Long-Term Success in Recurrent Rhinophyma
Case report describes recurrence-free outcomes at 18 months following treatment for triple-recurrent disease.
June 4, 2026
-
3 min
